Literature DB >> 2137154

Identification of a novel type 2 fiber population in mammalian skeletal muscle by combined use of histochemical myosin ATPase and anti-myosin monoclonal antibodies.

L Gorza1.   

Abstract

A novel type of myosin heavy chain (MHC), called 2X, has been recently identified in type 2 fibers of rat skeletal muscles using an immunochemical approach. In the present study, the same panel of anti-MHC monoclonal antibodies was used in immunohistochemistry combined with enzyme histochemistry to identify and compare type 2X fibers in hindlimb skeletal muscles of rat, mouse, and guinea pig. Immunohistochemistry shows that 2X MHC is localized in a large subset of type 2 fibers and is co-expressed with 2A or 2B MHC in a small number of fibers. Enzyme histochemistry shows that type 2X fibers display low myosin ATPase activity after pre-incubation at pH 4.3 and high activity after paraformaldehyde pre-incubation at pH 10.4. After pre-incubation at pH 4.6, myosin ATPase shows intermediate and high activity in rat and mouse 2X fibers, respectively, whereas it is low in guinea pig 2X fibers. Succinate dehydrogenase displays moderate to high activity in 2X fibers of all species. Taken together, these staining patterns allow this novel fiber population to be distinguished from the other type 2 fibers using only enzyme histochemistry. Nevertheless, the combined use of immuno- and enzyme histochemistry prevents incorrect fiber typing due to the interspecies variability of myosin ATPase activity among the correspondent fiber types, and completely modifies the presently used classification of mouse type 2 fibers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137154     DOI: 10.1177/38.2.2137154

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  64 in total

1.  Regional differences in fibre type composition in the human temporalis muscle.

Authors:  J A Korfage; T M Van Eijden
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

2.  Muscle fibre types in the suprahyoid muscles of the rat.

Authors:  A R Cobos; L A Segade; I Fuentes
Journal:  J Anat       Date:  2001-03       Impact factor: 2.610

3.  Three-dimensional study of the capillary supply of skeletal muscle fibres using confocal microscopy.

Authors:  L Kubínová; J Janácek; S Ribaric; V Cebasek; I Erzen
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

4.  Immunocytochemical characteristics of elbow, knee and ankle muscles of the five-toed jerboa (Allactaga elater).

Authors:  F K Jouffroy; M F Medina; S Renous; J P Gasc
Journal:  J Anat       Date:  2003-04       Impact factor: 2.610

5.  Quantitative determination of calcium-activated myosin adenosine triphosphatase activity in rat skeletal muscle fibres.

Authors:  C E Blanco; G C Sieck
Journal:  Histochem J       Date:  1992-07

6.  Presence of cardiac alpha-myosin correlates with histochemical myosin Ca2+ ATPase activity in rabbit masseter muscle.

Authors:  J J Bredman; W A Weijs; A F Moorman
Journal:  Histochem J       Date:  1992-05

7.  Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi.

Authors:  M J Kushmerick; T S Moerland; R W Wiseman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Stretch activation, unloaded shortening velocity, and myosin heavy chain isoforms of rat skeletal muscle fibres.

Authors:  S Galler; T L Schmitt; D Pette
Journal:  J Physiol       Date:  1994-08-01       Impact factor: 5.182

9.  AMPK regulates basal skeletal muscle capillarization and VEGF expression, but is not necessary for the angiogenic response to exercise.

Authors:  Kevin A Zwetsloot; Lenna M Westerkamp; Burton F Holmes; Timothy P Gavin
Journal:  J Physiol       Date:  2008-10-27       Impact factor: 5.182

10.  Dynamic nature of fibre-type specific expression of myosin heavy chain transcripts in 14 different human skeletal muscles.

Authors:  V Smerdu; I Erzen
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.